← Back to Search
Fucoidan As A Marine Anticancer Agent In Preclinical Development
Published 2014 · Biology, Medicine
Download PDFAnalyze on Scholarcy
Fucoidan is a fucose-containing sulfated polysaccharide derived from brown seaweeds, crude extracts of which are commercially available as nutritional supplements. Recent studies have demonstrated antiproliferative, antiangiogenic, and anticancer properties of fucoidan in vitro. Accordingly, the anticancer effects of fucoidan have been shown to vary depending on its structure, while it can target multiple receptors or signaling molecules in various cell types, including tumor cells and immune cells. Low toxicity and the in vitro effects of fucoidan mentioned above make it a suitable agent for cancer prevention or treatment. However, preclinical development of natural marine products requires in vivo examination of purified compounds in animal tumor models. This review discusses the effects of systemic and local administration of fucoidan on tumor growth, angiogenesis, and immune reaction and whether in vivo and in vitro results are likely applicable to the development of fucoidan as a marine anticancer drug.
This paper references
Scavenger receptor‐A mediates gp96/GRP94 and calreticulin internalization by antigen‐presenting cells
B. Berwin (2003)
Fucoidan Inhibited 4T1 Mouse Breast Cancer Cell Growth In Vivo and In Vitro Via Downregulation of Wnt/β-Catenin Signaling
Meilan Xue (2013)
Sulfated glycans induce rapid hematopoietic progenitor cell mobilization: evidence for selectin-dependent and independent mechanisms.
P. Frenette (2000)
Inhibition of selectin function and leukocyte rolling protects against dextran sodium sulfate-induced murine colitis.
X. W. Zhang (2001)
Protective effect of fucoidan against acetaminophen-induced liver injury
Sang-Won Hong (2012)
Ligand of scavenger receptor class A indirectly induces maturation of human blood dendritic cells via production of tumor necrosis factor-alpha.
Jun-O Jin (2009)
Antitumor and antimetastatic activity of fucoidan, a sulfated polysaccharide isolated from the Okhotsk sea Fucus evanescens brown alga
T. V. Alekseyenko (2007)
Fucoidan Extract Enhances the Anti-Cancer Activity of Chemotherapeutic Agents in MDA-MB-231 and MCF-7 Breast Cancer Cells
Z. Zhang (2013)
Fucoidan cures infection with both antimony-susceptible and -resistant strains of Leishmania donovani through Th1 response and macrophage-derived oxidants.
Susanta Kar (2011)
Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
Dingzhen Luo (2009)
Peritoneal injection of fucoidan suppresses the increase of plasma IgE induced by OVA-sensitization.
Y. Yanase (2009)
Fucoidin, but not yeast polyphosphomannan PPME, inhibits leukocyte rolling in venules of the rat mesentery.
K. Ley (1993)
Ovarian tumor-induced T cell suppression is alleviated by vascular leukocyte depletion.
S. Peter (2009)
B Furusato (2010)
Scavenger receptor-A negatively regulates antitumor immunity.
X. Wang (2007)
Structural Characteristics and Anticancer Activity of Fucoidan from the Brown Alga Sargassum mcclurei
Pham Duc Thinh (2013)
Fucoidan prevents concanavalin A-induced liver injury through induction of endogenous IL-10 in mice.
A. Saito (2006)
Fucanomics and galactanomics: current status in drug discovery, mechanisms of action and role of the well-defined structures.
V. Pomin (2012)
Overcoming resistance to antiangiogenic therapies.
S. Tejpar (2012)
The Anticancer Effect of Fucoidan in PC-3 Prostate Cancer Cells
Hye-Jin Boo (2013)
Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale.
N. Platt (2001)
Immunomodulatory activity of fucoidan against aspirin-induced gastric mucosal damage in rats.
H. Raghavendran (2011)
Effects of Polysaccharide Fucoidin on Cerebrospinal Fluid Interleukin-1 and Tumor Necrosis Factor Alpha in Pneumococcal Meningitis in the Rabbit
C. Granert (1999)
Fucoidan extract derived from Undaria pinnatifida inhibits angiogenesis by human umbilical vein endothelial cells.
Fang Liu (2012)
Structure, biology, evolution, and medical importance of sulfated fucans and galactans.
V. Pomin (2008)
Immunostimulatory effects of fucoidan on bone marrow-derived dendritic cells.
Mi-hyoung Kim (2008)
In vitro antioxidant properties of crude extracts and compounds from brown algae.
E. Balboa (2013)
Brown seaweed fucoidan: biological activity and apoptosis, growth signaling mechanism in cancer.
K. Senthilkumar (2013)
Pilot clinical study to evaluate the anticoagulant activity of fucoidan
M. Irhimeh (2009)
A combined Phase I and II open-label study on the immunomodulatory effects of seaweed extract nutrient complex
S. Myers (2011)
Suppression by Fucoidan of Liver Fibrogenesis via the TGF-β/Smad Pathway in Protecting against Oxidative Stress
Sang-Won Hong (2011)
Effects of molecular weight and hydrolysis conditions on anticancer activity of fucoidans from sporophyll of Undaria pinnatifida.
Chen Yang (2008)
Fucoidan from Sargassum sp. and Fucus vesiculosus reduces cell viability of lung carcinoma and melanoma cells in vitro and activates natural killer cells in mice in vivo.
M. T. Ale (2011)
CXCR4 and cancer
B. Furusato (2010)
The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention.
J. Lambert (2010)
Chemoattractant-induced firm adhesion of leukocytes to vascular endothelium in vivo is critically dependent on initial leukocyte rolling.
L. Lindbom (1992)
A radical approach to treatment
J L Cleveland (2000)
Low-Molecular-Weight Fucoidan Promotes Therapeutic Revascularization in a Rat Model of Critical Hindlimb Ischemia
C. Luyt (2003)
Repetitive Injections of Dendritic Cells Matured with Tumor Necrosis Factor α Induce Antigen-specific Protection of Mice from Autoimmunity
M. Menges (2002)
The effects of fucoidan extracts on CCl4-induced liver injury
Kum Suk Kang (2008)
The role of NK cells in antitumor activity of dietary fucoidan from Undaria pinnatifida sporophylls (Mekabu).
H. Maruyama (2006)
Induction of Apoptosis by Fucoidan in Human Leukemia U937 Cells through Activation of p38 MAPK and Modulation of Bcl-2 Family
H. Park (2013)
Low molecular weight fucoidan and heparin enhance the basic fibroblast growth factor-induced tube formation of endothelial cells through heparan sulfate-dependent alpha6 overexpression.
D. Chabut (2003)
Fucoidin enhances dendritic cell-mediated T-cell cytotoxicity against NY-ESO-1 expressing human cancer cells.
Yaling Hu (2010)
Macrophage Scavenger Receptor A Promotes Tumor Progression in Murine Models of Ovarian and Pancreatic Cancer
Claudine Neyen (2013)
Structural diversity of heparan sulfate binding domains in chemokines
H. Lortat-Jacob (2002)
Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets.
Laure Bachelet (2009)
Inhibition of leukocyte rolling with polysaccharide fucoidin prevents pleocytosis in experimental meningitis in the rabbit.
C. Granert (1994)
Cancer: A radical approach to treatment
J. Cleveland (2000)
Fucoidan, a sulfated polysaccharide from brown algae, against myocardial ischemia-reperfusion injury in rats via regulating the inflammation response.
C. Li (2011)
Requirement of L-selectin for gammadelta T lymphocyte activation and migration during allergic pleurisy: co-relation with eosinophil accumulation.
M. Costa (2009)
A combined phase I and II open label study on the effects of a seaweed extract nutrient complex on osteoarthritis
S. Myers (2010)
Fucoidan ingestion increases the expression of CXCR4 on human CD34+ cells.
M. Irhimeh (2007)
Role of scavenger receptor type A in the migration of dendritic cells and immunogenic antitumor effects by fucoidan
C. H. Kim (2014)
Fucoidan Protects against Lipopolysaccharide‐Induced Rat Neuronal Damage and Inhibits the Production of Proinflammatory Mediators in Primary Microglia
Yan-qiu Cui (2012)
Anticancer Properties and Mechanisms of Fucoidan on Mouse Breast Cancer In Vitro and In Vivo
Meilan Xue (2012)
New insights on the role of CXCR4 in cancer metastasis
A. Zlotnik (2008)
Antitumor activity and immune response of Mekabu fucoidan extracted from Sporophyll of Undaria pinnatifida.
H. Maruyama (2003)
Structure, biological activity, and enzymatic transformation of fucoidans from the brown seaweeds
M. Kusaykin (2008)
Tumor necrosis factor-alpha induces leukocyte recruitment by different mechanisms in vivo and in vitro.
M. Hickey (1997)
Low Molecular Weight Fucoidan and Heparin Enhance the Basic Fibroblast Growth Factor-Induced Tube Formation of Endothelial Cells through Heparan Sulfate-Dependent 6 Overexpression
D. Chabut (2003)
Low Molecular Weight Fucoidan Prevents Neointimal Hyperplasia After Aortic Allografting
Caroline Fréguin-Bouilland (2007)
Sulfated polysaccharides in inflammation.
K. Arfors (1993)
Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
H. Hsu (2013)
Fucoidan Inhibits the Growth of Hepatocellular Carcinoma Independent of Angiogenesis
C. Zhu (2013)
Oversulfated fucoidan inhibits the basic fibroblast growth factor-induced tube formation by human umbilical vein endothelial cells: its possible mechanism of action.
S. Soeda (2000)
Cytokine patterns in patients with cancer: a systematic review.
B. Lippitz (2013)
Cytokines and hematopoietic stem cell mobilization
B. Nervi (2006)
Effect of fucoidan on aspirin-induced stomach ulceration in rats.
J. Choi (2010)
Low Molecular Weight Fucoidan Prevents Neointimal Hyperplasia in Rabbit Iliac Artery In-Stent Restenosis Model
Jean-François Deux (2002)
Low molecular weight fucoidan promotes FGF-2-induced vascular tube formation by human endothelial cells, with decreased PAI-1 release and ICAM-1 downregulation.
D. Chabut (2004)
The integrin αMβ2 anchors hematopoietic progenitors in the bone marrow during enforced mobilization
Andrés Hidalgo (2004)
The mechanism of fucoidan‐induced apoptosis in leukemic cells: Involvement of ERK1/2, JNK, glutathione, and nitric oxide
Jun-O Jin (2010)
Tumor necrosis factor-α induces leukocyte recruitment by different mechanisms in vivo and in vitro
M. J. Hickey (1997)
Toxicological evaluation of fucoidan extracted from Laminaria japonica in Wistar rats.
N. Li (2005)
Expression of the class A macrophage scavenger receptor on specific subpopulations of murine dendritic cells limits their endotoxin response
Mike Becker (2006)
Cancer immunotherapy via dendritic cells
K. Palucka (2012)
Therapeutic Potential of Fucoidan in Myocardial Ischemia
S. Manzo-Silberman (2011)
Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis.
M. Brown (1983)
Fucoidan Extract Induces Apoptosis in MCF-7 Cells via a Mechanism Involving the ROS-Dependent JNK Activation and Mitochondria-Mediated Pathways
Z. Zhang (2011)
CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
B. Teicher (2010)
Low Molecular Weight Fucoidan against Renal Ischemia–Reperfusion Injury via Inhibition of the MAPK Signaling Pathway
J. Chen (2013)
Effects of Oral Administration of Fucoidan Extracted from Cladosiphon okamuranus on Tumor Growth and Survival Time in a Tumor-Bearing Mouse Model
K. Azuma (2012)
Fucoidin, a potent inhibitor of leukocyte rolling, prevents neutrophil influx into phorbol-ester-induced inflammatory sites in rabbit lungs.
M. Shimaoka (1996)
Anti-tumor activity of fucoidan is mediated by nitric oxide released from macrophages.
K. Takeda (2012)
Stabilization of mitochondrial and microsomal function of fucoidan from Sargassum plagiophyllum in diethylnitrosamine induced hepatocarcinogenesis.
V. Suresh (2013)
Sulfated malto‐oligosaccharides bind to basic FGF, inhibit endothelial cell proliferation, and disrupt endothelial cell tube formation
C. Foxall (1996)
Mobilization of stem/progenitor cells by sulfated polysaccharides does not require selectin presence.
E. Sweeney (2000)
Characterization of the Stromal Cell-derived Factor-1α-Heparin Complex*
R. Sadir (2001)
Sulfated fucans, fresh perspectives: structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide.
O. Berteau (2003)
Fucoidan Derived from Undaria pinnatifida Induces Apoptosis in Human Hepatocellular Carcinoma SMMC-7721 Cells via the ROS-Mediated Mitochondrial Pathway
L. Yang (2013)
Fucoidan induces nitric oxide production via p38 mitogen-activated protein kinase and NF-kappaB-dependent signaling pathways through macrophage scavenger receptors.
T. Nakamura (2006)
Suppression of Th2 Immune Responses by Mekabu Fucoidan from Undaria pinnatifida Sporophylls
H. Maruyama (2005)
Sulfated polysaccharides identified as inducers of neuropilin-1 internalization and functional inhibition of VEGF165 and semaphorin3A.
Masashi Narazaki (2008)
Class A scavenger receptor deficiency exacerbates lung tumorigenesis by cultivating a procarcinogenic microenvironment in humans and mice.
J. Ben (2012)
Major Vault Protein Regulates Class A Scavenger Receptor-mediated Tumor Necrosis Factor-α Synthesis and Apoptosis in Macrophages*
J. Ben (2013)
Sulfated Polysaccharide Fucoidan Ameliorates Experimental Autoimmune Myocarditis in Rats
K. Tanaka (2011)
FEEL-1 and FEEL-2 Are Endocytic Receptors for Advanced Glycation End Products*
Y. Tamura (2003)
Delayed growth of EL4 lymphoma in SR‐A‐deficient mice is due to upregulation of nitric oxide and interferon‐γ production by tumor‐associated macrophages
Y. Komohara (2009)
Fucoidan stimulation induces a functional maturation of human monocyte-derived dendritic cells.
M. Yang (2008)
Low molecular weight fucoidan promotes FGF-2-induced vascular tube formation by human endothelial cells, with decreased PAI-1 release and ICAM-1 downregulation. Thrombosis Res
D Chabut (2004)
Therapies from Fucoidan; Multifunctional Marine Polymers
J. H. Fitton (2011)
Antiproliferative activity of fucoidan was associated with the induction of apoptosis and autophagy in AGS human gastric cancer cells.
H. Park (2011)
Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: involvement in mobilization of stem/progenitor cells.
E. Sweeney (2002)
SREC-I, a Type F Scavenger Receptor, Is an Endocytic Receptor for Calreticulin*
B. Berwin (2004)
Fucoidan derived from Cladosiphon okamuranus Tokida ameliorates murine chronic colitis through the down‐regulation of interleukin‐6 production on colonic epithelial cells
S. Matsumoto (2004)
Marine-Derived Angiogenesis Inhibitors for Cancer Therapy
Ying-qing Wang (2013)
Increase in Circulating SDF‐1 after Treatment with Sulfated Glycans
E. Sweeney (2001)
Ovarian Cancer Cells Polarize Macrophages Toward A Tumor-Associated Phenotype1
T. Hagemann (2006)
Enzyme-digested Fucoidan Extracts Derived from Seaweed Mozuku of Cladosiphon novae-caledoniaekylin Inhibit Invasion and Angiogenesis of Tumor Cells
J. Ye (2005)
Lipid accumulation and dendritic cell dysfunction in cancer
Donna L. Herber (2010)
Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities.
S. Koyanagi (2003)
Fucoidan from Undaria pinnatifida Induces Apoptosis in A549 Human Lung Carcinoma Cells
Hye-Jin Boo (2011)
Scavenger receptor-A-targeted leukocyte depletion inhibits peritoneal ovarian tumor progression.
S. Bak (2007)
The function of scavenger receptors expressed by macrophages and their role in the regulation of inflammation.
L. Peiser (2001)
Neuroprotective effect of fucoidin on lipopolysaccharide accelerated cerebral ischemic injury through inhibition of cytokine expression and neutrophil infiltration
G. Kang (2012)
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license
Stromal Cell-derived Factor-1α Associates with Heparan Sulfates through the First β-Strand of the Chemokine*
A. Amara (1999)
Caveolae-dependent Endocytosis Is Required for Class A Macrophage Scavenger Receptor-mediated Apoptosis in Macrophages*
X. Zhu (2011)
Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages
T. Seimon (2006)
This paper is referenced by
Fucoidan inhibits CCL22 production through NF-κB pathway in M2 macrophages: a potential therapeutic strategy for cancer
J. Sun (2016)
Expression and biochemical characterization and substrate specificity of the fucoidanase from Formosa algae
A. Silchenko (2017)
Fucoidan Supplementation Restores Fecal Lysozyme Concentrations in High-Performance Athletes: A Pilot Study
A. Cox (2020)
Fucoidans: pro- or antiangiogenic agents?
N. Ustyuzhanina (2014)
Fucoidan Exerts Anticancer Effects Against Head and Neck Squamous Cell Carcinoma In Vitro
W. Blaszczak (2018)
Marine Biomaterials‐Based Systems: Delivery of Therapeutics
Sougata Jana (2020)
Branched architecture of fucoidan characterized by dynamic and static light scattering
E. Gasilova (2020)
Antiviral activity of a polysaccharide from Laminaria japonica against enterovirus 71.
Yingying Yue (2017)
Poly-allylamine hydrochloride and fucoidan-based self-assembled polyelectrolyte complex nanoparticles for cancer therapeutics.
P. Wang (2019)
The anti-cancer activity of the natural product, fucoidan, in haematological malignancies
F. Atashrazm (2016)
Fucoidan attenuates radioiodine-induced salivary gland dysfunction in mice
Y. Kim (2019)
Fucoidan and its potential as a complementary agent in cancer therapy
Wiktoria Blaszczak (2017)
Low-Molecular-Weight Fucoidan Attenuates Mitochondrial Dysfunction and Improves Neurological Outcome After Traumatic Brain Injury in Aged Mice: Involvement of Sirt3
Tao Wang (2015)
MARITECH ORGANIC FUCOIDANS THE SCIENCE
Dr J. Helen Fitton (2018)
Selectins—The Two Dr. Jekyll and Mr. Hyde Faces of Adhesion Molecules—A Review
I. Tvaroška (2020)
Fucoidan from seaweed Fucus vesiculosus inhibits 2,4-dinitrochlorobenzene-induced atopic dermatitis.
T. Tian (2019)
Phycochemical Constituents and Biological Activities of Fucus spp.
M. D. Catarino (2018)
Fucoidan from Sea Cucumber Holothuria polii: Structural Elucidation and Stimulation of Hematopoietic Activity.
Chao Li (2019)
Charles Darwin University Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo Atashrazm,
F. Lowenthal (2016)
Fucoidan from Macrocystis pyrifera Has Powerful Immune-Modulatory Effects Compared to Three Other Fucoidans
Wei Zhang (2015)
Marine Non-Glycosaminoglycan Sulfated Glycans as Potential Pharmaceuticals
V. Pomin (2015)
Optimisation of ultrasound-assisted extraction conditions for phenolic content and antioxidant activities of the alga Hormosira banksii using response surface methodology
T. T. Dang (2017)
In vitro and in vivo anti-primary effusion lymphoma activities of fucoidan extracted from Cladosiphon okamuranus Tokida.
Chie Ishikawa (2017)
The Effect of Undaria pinnatifida Fucoidan on the Pharmacokinetics of Letrozole and Tamoxifen in Patients With Breast Cancer
S. Tocaciu (2018)
Usage of Seaweed Polysaccharides as Nutraceuticals
I. Wijesekara (2017)
Protective Effects of Fucoidan on Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells and Progression of Proliferative Vitreoretinopathy
Y. Zhang (2018)
Evaluation of adjuvant effects of fucoidan for improving vaccine efficacy
S. Kim (2015)
Ameliorated and antioxidant effects of Fucoidan against cyclosporine A-induced kidney injury in rats
Bushra Y. Al-Khatib (2019)
Degraded Fucoidan Fractions and β-1,3-Glucan Sulfates Inhibit CXCL12-induced Erk1/2 Activation and Chemotaxis in Burkitt Lymphoma Cells.
Inga Techel (2019)
Spray-dried fucoidan microparticles for pulmonary delivery of antitubercular drugs
Ludmylla Cunha (2018)
Epigenetic Modification and Differentiation Induction of Malignant Glioma Cells by Oligo-Fucoidan
Chien-Huang Liao (2019)
Cytotoxic activity of ten algae from the Persian Gulf and Oman Sea on human breast cancer cell lines; MDA-MB-231, MCF-7, and T-47D
N. Erfani (2015)See more